End Points for Clinical Trials in Acute Kidney Injury

American Journal of Kidney Diseases

Volumn 69, Issue 1, 2017, Pages 108-116

  Leaf, David E ^a   Waikar, Sushrut S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute kidney injury (AKI); acute renal failure (ARF); AKDI definition; biomarker; clinical trial; end point; outcome; randomized controlled trial; study design

Indexed keywords

BIOLOGICAL MARKER;

ACUTE KIDNEY FAILURE; ARTICLE; CONTRAST INDUCED NEPHROPATHY; DIALYSIS; HEART SURGERY; HOSPITAL PATIENT; HUMAN; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; ACUTE KIDNEY INJURY; CLINICAL TRIAL (TOPIC);

ACUTE KIDNEY INJURY; CLINICAL TRIALS AS TOPIC; HUMANS;

EID: 84992426209     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.05.033     Document Type: Article

References (54)

1. 1 Wang, H.E., Muntner, P., Chertow, G.M., Warnock, D.G., Acute kidney injury and mortality in hospitalized patients. Am J Nephrol 35:4 (2012), 349–355.
2. 2 Loef, B.G., Epema, A.H., Smilde, T.D., et al. Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16:1 (2005), 195–200.
3. 3 Lassnigg, A., Schmidlin, D., Mouhieddine, M., et al. Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study. J Am Soc Nephrol 15:6 (2004), 1597–1605.
4. 4 Waikar, S.S., Curhan, G.C., Wald, R., McCarthy, E.P., Chertow, G.M., Declining mortality in patients with acute renal failure, 1988 to 2002. J Am Soc Nephrol 17:4 (2006), 1143–1150.
5. 5 Chertow, G.M., Burdick, E., Honour, M., Bonventre, J.V., Bates, D.W., Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 16:11 (2005), 3365–3370.
6. 6 Horkan, C.M., Purtle, S.W., Mendu, M.L., Moromizato, T., Gibbons, F.K., Christopher, K.B., The association of acute kidney injury in the critically ill and postdischarge outcomes: a cohort study*. Crit Care Med 43:2 (2015), 354–364.
7. 7 Chawla, L.S., Amdur, R.L., Shaw, A.D., Faselis, C., Palant, C.E., Kimmel, P.L., Association between AKI and long-term renal and cardiovascular outcomes in United States veterans. Clin J Am Soc Nephrol 9:3 (2014), 448–456.
8. 8 Chawla, L.S., Amdur, R.L., Amodeo, S., Kimmel, P.L., Palant, C.E., The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int 79:12 (2011), 1361–1369.
9. 9 Ishani, A., Xue, J.L., Himmelfarb, J., et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol 20:1 (2009), 223–228.
10. 10 Lo, L.J., Go, A.S., Chertow, G.M., et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int 76:8 (2009), 893–899.
11. 11 Wald, R., Quinn, R.R., Luo, J., et al. Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 302:11 (2009), 1179–1185.
12. 12 Devarajan, P., Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury. Biomark Med 4:2 (2010), 265–280.
13. 13 Mehta, R.L., Chertow, G.M., Acute renal failure definitions and classification: time for change?. J Am Soc Nephrol 14:8 (2003), 2178–2187.
14. 14 Coca, S.G., Yalavarthy, R., Concato, J., Parikh, C.R., Biomarkers for the diagnosis and risk stratification of acute kidney injury: a systematic review. Kidney Int 73:9 (2008), 1008–1016.
15. 15 Siew, E.D., Ware, L.B., Ikizler, T.A., Biological markers of acute kidney injury. J Am Soc Nephrol 22:5 (2011), 810–820.
16. 16 Endre, Z.H., Walker, R.J., Pickering, J.W., et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int 77:11 (2010), 1020–1030.
17. 17 Parikh, C.R., Coca, S.G., Thiessen-Philbrook, H., et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol 22:9 (2011), 1748–1757.
18. 18 Bellomo, R., Ronco, C., Kellum, J.A., Mehta, R.L., Palevsky, P., Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8:4 (2004), R204–R212.
19. 19 Mehta, R.L., Kellum, J.A., Shah, S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care, 2007, 10.1186/cc5713.
20. 20 Kidney Disease; Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl 2 (2012), 1–138.
21. 21 Levy, E.M., Viscoli, C.M., Horwitz, R.I., The effect of acute renal failure on mortality. A cohort analysis. JAMA 275:19 (1996), 1489–1494.
22. 22 Harjai, K.J., Raizada, A., Shenoy, C., et al. A comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system. Am J Cardiol 101:6 (2008), 812–819.
23. 23 Chawla, L.S., Eggers, P.W., Star, R.A., Kimmel, P.L., Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med 371:1 (2014), 58–66.
24. 24 Garg, A.X., Devereaux, P.J., Yusuf, S., et al. Kidney function after off-pump or on-pump coronary artery bypass graft surgery: a randomized clinical trial. JAMA 311:21 (2014), 2191–2198.
25. 25 Russo, D., Minutolo, R., Cianciaruso, B., Memoli, B., Conte, G., De Nicola, L., Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure. J Am Soc Nephrol 6:5 (1995), 1451–1458.
26. 26 Weisbord, S.D., Gallagher, M., Kaufman, J., et al. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clin J Am Soc Nephrol 8:9 (2013), 1618–1631.
27. 27 Billings, F.T., Shaw, A.D., Clinical trial endpoints in acute kidney injury. Nephron Clin Pract 127:1-4 (2014), 89–93.
28. 28 Ferreira-Gonzalez, I., Busse, J.W., Heels-Ansdell, D., et al. Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials. BMJ, 334(7597), 2007, 786.
29. 29 Lewis, E.J., Hunsicker, L.G., Clarke, W.R., et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 345:12 (2001), 851–860.
30. 30 Rifkin, D.E., Coca, S.G., Kalantar-Zadeh, K., Does AKI truly lead to CKD?. J Am Soc Nephrol 23:6 (2012), 979–984.
31. 31 Hsu, C.Y., Yes, AKI truly leads to CKD. J Am Soc Nephrol 23:6 (2012), 967–969.
32. 32 Prowle, J.R., Kolic, I., Purdell-Lewis, J., Taylor, R., Pearse, R.M., Kirwan, C.J., Serum creatinine changes associated with critical illness and detection of persistent renal dysfunction after AKI. Clin J Am Soc Nephrol 9:6 (2014), 1015–1023.
33. 33 Levey, A.S., Inker, L.A., Matsushita, K., et al. GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration. Am J Kidney Dis 64:6 (2014), 821–835.
34. 34 Jacob, K.A., Leaf, D.E., Dieleman, J.M., et al. Intraoperative high-dose dexamethasone and severe AKI after cardiac surgery. J Am Soc Nephrol 26:12 (2015), 2947–2951.
35. 35 Prentice, R.L., Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 8:4 (1989), 431–440.
36. 36 Stevens, L.A., Greene, T., Levey, A.S., Surrogate end points for clinical trials of kidney disease progression. Clin J Am Soc Nephrol 1:4 (2006), 874–884.
37. 37 Felker, G.M., Maisel, A.S., A global rank end point for clinical trials in acute heart failure. Circ Heart Fail 3:5 (2010), 643–646.
38. 38 Okusa, M.D., Rosner, M.H., Kellum, J.A., Ronco, C., Acute Dialysis Quality Initiative XIII Workgroup. Therapeutic targets of human AKI: harmonizing human and animal AKI. J Am Soc Nephrol 27:1 (2016), 44–48.
39. 39 Allgren, R.L., Marbury, T.C., Rahman, S.N., et al. Anaritide in acute tubular necrosis. Auriculin Anaritide Acute Renal Failure Study Group. N Engl J Med 336:12 (1997), 828–834.
40. 40 Rubenfeld, G.D., Angus, D.C., Pinsky, M.R., Curtis, J.R., Connors, A.F. Jr., Bernard, G.R., Outcomes research in critical care: results of the American Thoracic Society Critical Care Assembly Workshop on Outcomes Research. The Members of the Outcomes Research Workshop. Am J Respir Crit Care Med 160:1 (1999), 358–367.
41. 41 National Heart Lung and Blood Institute ARDS Clinical Trials Network, Truwit, J.D., Bernard, G.R., Steingrub, J., et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 370:23 (2014), 2191–2200.
42. 42 Leaf, D.E., Waikar, S.S., Rosuvastatin for sepsis-associated ARDS. N Engl J Med, 371(10), 2014, 968.
43. 43 VA/NIH Acute Renal Failure Trial Network, Palevsky, P.M., Zhang, J.H., O'Connor, T.Z., et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:1 (2008), 7–20.
44. 44 Cantarovich, F., Rangoonwala, B., Lorenz, H., Verho, M., Esnault, V.L., High-Dose Furosemide in Acute Renal Failure Study Group. High-dose furosemide for established ARF: a prospective, randomized, double-blind, placebo-controlled, multicenter trial. Am J Kidney Dis 44:3 (2004), 402–409.
45. 45 Holst, L.B., Haase, N., Wetterslev, J., et al. Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371:15 (2014), 1381–1391.
46. 46 Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60:16 (2012), 1581–1598.
47. 47 ARDS Definition Task Force, Ranieri, V.M., Rubenfeld, G.D., Thompson, B.T., et al. Acute respiratory distress syndrome: the Berlin definition. JAMA 307:23 (2012), 2526–2533.
48. 48 Polson, J., Lee, W.M., American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology 41:5 (2005), 1179–1197.
49. 49 Kaya, K., Oguz, M., Akar, A.R., et al. The effect of sodium nitroprusside infusion on renal function during reperfusion period in patients undergoing coronary artery bypass grafting: a prospective randomized clinical trial. Eur J Cardiothorac Surg 31:2 (2007), 290–297.
50. 50 Zimmerman, R.F., Ezeanuna, P.U., Kane, J.C., et al. Ischemic preconditioning at a remote site prevents acute kidney injury in patients following cardiac surgery. Kidney Int 80:8 (2011), 861–867.
51. 51 Kowalczyk, J., Lenarczyk, R., Kowalski, O., et al. Contrast-induced acute kidney injury in patients undergoing cardiac resynchronization therapy-incidence and prognostic importance. Sub-analysis of data from randomized TRUST CRT trial. J Interv Card Electrophysiol 40:1 (2014), 1–8.
52. 52 Er, F., Nia, A.M., Dopp, H., et al. Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial). Circulation 126:3 (2012), 296–303.
53. 53 Truwit, J.D., Bernard, G.R., Steingrub, J., et al. Rosuvastatin for sepsis-associated acute respiratory distress syndrome. N Engl J Med 370:23 (2014), 2191–2200.
54. 54 Ali, Z.A., Callaghan, C.J., Lim, E., et al. Remote ischemic preconditioning reduces myocardial and renal injury after elective abdominal aortic aneurysm repair: a randomized controlled trial. Circulation 116:11 suppl (2007), I98–I105.